Results: 9
Discounting health effects in pharmacoeconomic evaluations: current controversies.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Price differentiation and transparency in the global pharmaceutical marketplace.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Economic Evaluation of Etoricoxib versus Non-Selective NSAIDs in the Treatment of Osteoarthritis and Rheumatoid Arthritis Patients in the UK.
- Published in:
- PharmacoEconomics, 2005, v. 23, n. 7, p. 743, doi. 10.2165/00019053-200523070-00008
- By:
- Publication type:
- Article
The State of Patient-Reported Outcomes in Atrial Fibrillation: A Review of Current Measures.
- Published in:
- PharmacoEconomics, 2005, v. 23, n. 7, p. 687, doi. 10.2165/00019053-200523070-00004
- By:
- Publication type:
- Article
Introducing economic evaluation as a policy tool in Korea: will decision makers get quality information? : a critical review of published Korean economic evaluations.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Economic assessment of adjustable maintenance treatment with budesonide/formoterol in a single inhaler versus fixed treatment in asthma.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Costs and medical care consequences associated with the diagnosis of peripheral arterial disease.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Evaluating Health-Related Quality-of-Life Studies in Paediatric Populations: Some Conceptual, Methodological and Developmental Considerations and Recent Applications.
- Published in:
- PharmacoEconomics, 2005, v. 23, n. 7, p. 659, doi. 10.2165/00019053-200523070-00003
- By:
- Publication type:
- Article
The Authors' Reply.
- Published in:
- PharmacoEconomics, 2005, v. 23, n. 7, p. 743
- By:
- Publication type:
- Article